Tuesday, May 21, 2013

• Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical OfficerBusiness Wire( (Tue, May 21)

Thursday, May 16, 2013

• Oxygen Biotherapeutics Receives Favorable NASDAQ Listing DecisionBusiness Wire( (Thu, May 16)

Friday, May 10, 2013

• Oxygen Biotherapeutics Announces 20:1 Reverse Stock Split Effective After Market Close on May 10thBusiness Wire( (Fri, May 10)

Tuesday, April 30, 2013

• Oxygen Biotherapeutics Announces It is Set to Begin Enrolling Patients in the Second Cohort of Its STOP-TBI Clinical Trial in IsraelBusiness Wire( (Tue, Apr 30)

Monday, March 18, 2013

• Oxygen Biotherapeutics Reports Financial Results for the Third Quarter FY2013Business Wire( (Mon, Mar 18)

Wednesday, March 13, 2013

• Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and WebcastBusiness Wire( (Wed, Mar 13)

Friday, February 22, 2013

• Oxygen Biotherapeutics Enters into Definitive Agreements for Financing for up to $2.1 Million in Gross ProceedsBusiness Wire( (Fri, Feb 22)

Wednesday, February 20, 2013

• Oxygen Biotherapeutics Announces Tentative Settlement of LitigationBusiness Wire( (Wed, Feb 20)

Monday, February 11, 2013

• Oxygen Biotherapeutics Enters License and Supply Agreement for Dermacyte® Products with the Cosmetics Division of Valor SABusiness Wire( (Mon, Feb 11)

Wednesday, February 6, 2013

• Oxygen Biotherapeutics and the U.S. Army Institute of Surgical Research Sign a Cooperative Research and Development Agreement to Study the Effects of Oxycyte® on Ex Vivo Platelet FunctionBusiness Wire( (Wed, Feb 6)

Wednesday, January 30, 2013

• Oxygen Biotherapeutics Announces It Will Present at the 15th Annual BIO CEO & Investor Conference on February 11Business Wire( (Wed, Jan 30)

Tuesday, January 8, 2013

• Oxygen Biotherapeutics Announces It Will Present at OneMedForum Conference on Wednesday January 9thBusiness Wire( (Tue, Jan 8)

Monday, December 17, 2012

• Oxygen Biotherapeutics Reports Second Quarter FY2013 Financial ResultsBusiness Wire( (Mon, Dec 17)